# Dialysis Membranes and Hemodynamic Tolerance

> **NCT01898234** · NA · COMPLETED · sponsor: **Ospedale Regionale di Locarno** · enrollment: 25 (actual)

## Conditions studied

- Dialysis Membranes and Hemodynamic Tolerance

## Interventions

- **DEVICE:** Revaclear
- **DEVICE:** Helixone high flux
- **DEVICE:** Xevonta
- **DEVICE:** Helixone low flux

## Key facts

- **NCT ID:** NCT01898234
- **Lead sponsor:** Ospedale Regionale di Locarno
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898234, "Dialysis Membranes and Hemodynamic Tolerance". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01898234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*